IMM0306

· ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IMM0306, covering 2023-04-10 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma [Phase 3]

See pricing